Navigation Links
Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
Date:3/19/2008

ble

foreign currency effects, 2007 fourth quarter net sales would have

increased 3.8%.

-- Net sales of the rigid packaging segment increased $1.5 million, or

6.2%. The increase resulted primarily from favorable foreign currency

effects and sales volume improvement. Excluding the favorable foreign

currency effects, the segment's fourth quarter net sales were

relatively flat compared to the prior year.

A summary of a significant measure required by the Company's indentures is presented in the supplemental information at the end of this release.

Conference Call:

The Company will conduct an investor conference call to review its 2007 fourth quarter and full year results on Thursday, March 20, 2008 at 10:00 a.m. ET (9:00 a.m. CT). The call can be accessed through the following dial-in numbers: Domestic: 866-202-4367; International: 617-213-8845; Conference Passcode: 19710045. A replay of the conference call will be available through April 3, 2008. The replay may be accessed using the following dial-in information: Domestic: 888-286-8010; International: 617-801-6888; Conference Passcode: 83163494.

About Pregis:

Pregis Corporation is a leading global provider of innovative protective, flexible, and foodservice packaging and hospital supply products. The specialty-packaging leader currently operates 47 facilities in 18 countries around the world. Pregis Corporation is a wholly owned subsidiary of Pregis Holding II Corporation. For more information about Pregis, visit the Company's web site at http://www.pregis.com.

Safe Harbor Statement:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the Company's use of forward-looking terminology
'/>"/>

SOURCE Pregis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Pregis Corporation Appoints New President of Protective Packaging North America
2. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ead to new therapies for preterm labor , ... say they,ve found the switch that activates the u...a finding that may lead to therapies for preterm l...ds the protein IP on the surface of these uterine ...ing pregnancy. , But researchers from Dartmout...
(Date:11/21/2008)...a., Nov. 21 During a m...Edward G. Rendell today remembered Lieutenant Gove...an important partner in public service, and a tire... , "As the first woman elected lieutenant gove...vant," said Governor Rendell. "Her family and her ...
(Date:11/21/2008)... Banzel proved effective against Lennox-Gastaut sy...ws) -- A new drug called Banzel (rufinamide) has b...vere form of epilepsy called Lennox-Gastaut syndro...d Friday. , The approval was based on results o...ts ages 4 to 30. Compared to patients who took a p...
(Date:11/21/2008)...lders Intend To Vigorously Protect Investment And ...ov. 21 Dr. Stephen Joff...ndment to their Schedule 13D with the U.S. Securit... filed a 13D disclosing ownership of 11.4% of LCA-...LasikPlus fixed-site laser vision correction cente...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...loped a micro capsule coated with silicon, which c...ection.This microchip works by absorbing nutrient...ucing cells.Some diabetics have to inject insulin ...r blood sugar levels. The device is being develope...
...e of disability in the United States, affects more...ances in treatment options and educational efforts...d and poorly treated in the US. In fact, a recent ...ns with serious mental illness fail to receive ade...
...hat children have the greatest increase in bone mi...Children who do not take enough exercise are in da...ys the study. Many fail to strengthen up their ske...efore puberty, which is critical to building healt...
...evel electromagnetic fields (EMF) at home could do...national study has found. //The three-year review ...n Non-Ionizing Radiation Protection (ICNIRP) by si...nstitutions around the world. Leukemia, which deve...
Other Medicine News:
(Date:11/19/2008)... a contract development and,manufacturing organiz...st,phase launch of its contract facility in Delaw...he process, facility and capacity problems commonl...ow-volume clinical and,early-stage commercial ste...n invest over $100 million and four years to devel...
(Date:11/18/2008)... make a donation or send a Christmas Seals e-card ...ire/ -- Millions will receive Christmas Seals in t...Association. These decorative holiday stamps are p... to 1907 when the Lung Association led efforts to ... alive today have no vivid memories of how widespr...
(Date:11/18/2008)...luenza survey underscores that mothers need to get...Gold Medalist Kristi Yamaguchi joins initiative ,...e 78 percent of mothers in the United States consi...ening disease that can strike anyone, only half sa...this season, according to a new survey from the Am...
(Date:11/13/2008)...s Prior to Surgery, ARLINGTON HEIGHTS, Ill., Nov....ition before surgery in massive weight loss patien...ease surgical complications, accelerate,wound heal... levels,according to a study in the December issu...ficial medical journal of the American Society of ...
Breaking Medicine Technology:Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Millennium Pharmacy Systems Expands into West Virginia 28877 1Millennium Pharmacy Systems Expands into West Virginia 28877 2LifeMasters Receives Full Accreditation for Disease Management Programs 28872 1LifeMasters Receives Full Accreditation for Disease Management Programs 28872 2LifeMasters Receives Full Accreditation for Disease Management Programs 28872 3Brain recognizes verbal oh dear wave 5738 1Brain recognizes verbal oh dear wave 5738 2Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 1Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 2Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 3
...Onset and Total,Sleep Time, and key secondary endp... met at both doses - Evotec to host a,conference c...BURG, Germany | OXFORD, England, June 4, 2007-- Ev...today positive top-line,results from its first pha...hronic primary insomnia. EVT 201 is a partial,posi...
...ebo-controlled Trial,Ever Conducted in CTCL Presen...CHICAGO, June 04, 2007 /PRNewswire/ -- Preliminary...lled clinical trial ever,conducted in patients wit...AK was more than twice as effective as placebo in ...L. [Abstract number 8026],The primary endpoint of ...
Other Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 6
Vannas Capsulotomy scissors angled forward
Gills-Vannas side angled capsulotomy flat handle scissors
Vannas angled capsulotomy flat handle scissors
No. 1. 30 mm conventional blades. Thin well-rounded tips.
Medicine Products: